High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer.

Abstract

BACKGROUND:

Acetyl-CoA acetyltransferase 2 (ACAT2) is a lipid metabolism enzyme and rarely was researched in epithelial ovarian cancer (EOC).

METHODS:

ACAT2 expressions were confirmed in two pairs of cell lines (A2780 and A2780/DDP, OVCAR8 and OVCAR8/DDP) from Gene Expression Omnibus database by bioinformatics analysis, and in A2780 and A2780/DDP cell lines by quantitative real-time polymerase chain reaction and western blotting. Tissue samples were stained by immunohistochemistry and scored for ACAT2 expression. The relationships between ACAT2 expression and clinicopathological characteristics were analyzed by χ2 test. The prognosis of ACAT2 was analyzed by the log-rank tests and Cox regression models.

RESULTS:

ACAT2 was remarkably upregulated in the above drug-resistant cell lines by mRNA (all P < 0.05) and protein expression (P = 0.026) than those in sensitive ones. Patients were classified as ACAT2-high (n = 51) and ACAT2-low (n = 26) according to immunohistochemical score. ACAT2 expression had a significantly inverse correlation with FIGO stage (P = 0.030) and chemo-response (P = 0.041). A marginal statistical significance existed in ACAT2 expression and ascites volume (P = 0.092). Univariate analysis suggested that high-expressed ACAT2 was associated with decreased platinum-free interval (PFI) (8.57 vs. 14.13 months, P = 0.044), progression-free survival (PFS) (14.12 vs. 19.79 months, P = 0.039) and overall survival (OS) (36.89 vs. 52.40 months, P = 0.044). Multivariate analysis demonstrated that ACAT2 expression (hazard ratio = 2.18, 95% confidence interval: 1.15-4.11, P = 0.017) affected OS independently, rather than PFI and PFS.

CONCLUSION:

The expression of ACAT2 in A2780/DDP and OVCAR8/DDP was higher than the corresponding A2780 and OVCAR8. High-expressed ACAT2 was associated with advanced FIGO stage, chemo-resistance, and decreased PFI, PFS and OS. It was an independent prognostic factor of OS in EOC.

• Authors: Jinfeng Wang, Zhe Yang, Han Bai, Lanbo Zhao, Jing Ji, Yadi Bin, Yu Liu, Siyi Zhang, Huilian Hou, Qiling Li
• Journal: Diagnostic pathology (Diagn Pathol) Vol. 19 Issue 1 Pg. 7 (Jan 04 2024) ISSN: 1746-1596 [Electronic] England
• PMID: 38178203 (Publication Type: Journal Article)
• Copyright: © 2023. The Author(s).

Chemical References

• Acetyltransferases

Topics

• Female
• Humans
• Acetyltransferases
• Carcinoma, Ovarian Epithelial (pathology)
• Cell Line, Tumor
• Ovarian Neoplasms (pathology)
• Prognosis
• Drug Resistance, Neoplasm